These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 16247648

  • 1. C1Q nephropathy in children.
    Kersnik Levart T, Kenda RB, Avgustin Cavić M, Ferluga D, Hvala A, Vizjak A.
    Pediatr Nephrol; 2005 Dec; 20(12):1756-61. PubMed ID: 16247648
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. C1q nephropathy in two young sisters.
    Kari JA, Jalalah SM.
    Pediatr Nephrol; 2008 Mar; 23(3):487-90. PubMed ID: 17952693
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM.
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome?
    Davenport A, Maciver AG, Mackenzie JC.
    Nephrol Dial Transplant; 1992 Oct; 7(5):391-6. PubMed ID: 1321373
    [Abstract] [Full Text] [Related]

  • 11. Pathology, clinical presentations, and outcomes of C1q nephropathy.
    Vizjak A, Ferluga D, Rozic M, Hvala A, Lindic J, Levart TK, Jurcić V, Jennette JC.
    J Am Soc Nephrol; 2008 Nov; 19(11):2237-44. PubMed ID: 18650484
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Predominant but silent C1q deposits in mesangium on transplanted kidneys - long-term observational study.
    Kanai T, Akioka Y, Miura K, Hisano M, Koike J, Yamaguchi Y, Hattori M.
    BMC Nephrol; 2018 Apr 06; 19(1):82. PubMed ID: 29625558
    [Abstract] [Full Text] [Related]

  • 14. C1q nephropathy: features at presentation and outcome.
    Lau KK, Gaber LW, Delos Santos NM, Wyatt RJ.
    Pediatr Nephrol; 2005 Jun 06; 20(6):744-9. PubMed ID: 15827744
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis.
    Srivastava T, Chadha V, Taboada EM, Alon US.
    Pediatr Nephrol; 2000 Sep 06; 14(10-11):976-9. PubMed ID: 10975310
    [Abstract] [Full Text] [Related]

  • 18. IgG nephropathy - confusion and overlap with C1q nephropathy.
    Lim BJ, Hong SW, Jeong HJ.
    Clin Nephrol; 2009 Nov 06; 72(5):360-5. PubMed ID: 19863878
    [Abstract] [Full Text] [Related]

  • 19. A single-center study of C1q nephropathy in children.
    Roberti I, Baqi N, Vyas S, Kim DU.
    Pediatr Nephrol; 2009 Jan 06; 24(1):77-82. PubMed ID: 18688655
    [Abstract] [Full Text] [Related]

  • 20. The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change.
    McAdams AJ, Valentini RP, Welch TR.
    Medicine (Baltimore); 1997 Jan 06; 76(1):42-52. PubMed ID: 9064487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.